Skip to content

Vasodilator Free Measure of Fractional Flow Reserve

ADenosine Vasodilator Independent Stenosis Evaluation Study (ADVISE)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01118481
Acronym
ADVISE
Enrollment
157
Registered
2010-05-06
Start date
2010-01-31
Completion date
2011-06-30
Last updated
2017-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Stenosis

Keywords

Coronary stenosis, Wave intensity analysis, Instantaneous Flow Reserve, iFR, Fractional Flow Reserve

Brief summary

Narrowing of coronary arteries interferes with blood flow and can cause chest pain. Cardiologists sometimes quantify the extent of the narrowing by measuring the fractional flow reserve (the ratio of the pressure in the aorta to the pressure downstream of the narrowing under conditions of maximal flow). We propose a new technique based on principles of wave intensity analysis (WIA) to better assess coronary stenosis and the significance of the narrowing without the need for administration of vasodilator agents such as adenosine. This would simplify assessment and improve our ability to advise patients whether stent treatment will help their symptoms.

Interventions

None listed

Sponsors

Hospital San Carlos, Madrid
CollaboratorOTHER
Imperial College London
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with coronary stenosis

Exclusion criteria

* Patient's with cardiac pacemakers, valvular heart disease, and chronic renal failure * Unable to consent * Contraindications to adenosine * Contraindications to cardiac MRI

Design outcomes

Primary

MeasureTime frame
Correlation and descriptive characteristics between adenosine free measure of stenosis severity and FFRStudy end

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 27, 2026